Clinical Edge Journal Scan

Migraine tied to a greater risk for rheumatoid arthritis


 

Key clinical point: Patients with migraine are at a greater risk of experiencing rheumatoid arthritis (RA) attacks, with the risk being prominently higher among those having migraine without aura.

Major finding: The risk for RA was 1.94 times higher in patients with migraine vs control individuals (adjusted odds ratio [aOR] 1.94; 95% CI 1.74-2.17), with the risk being prominent in those with migraine without aura (aOR 1.49; 95% CI 1.35-1.64).

Study details: The data come from a meta-analysis of five studies including 321,877 participants.

Disclosures: This study did not disclose the funding source. The authors declared no competing interests.

Source: Tian D et al. Migraine and risk of rheumatoid arthritis: A systematic review and meta-analysis of observational studies. Heliyon. 2023;9(8):e18430 (Jul 18). doi: 10.1016/j.heliyon.2023.e18430

Recommended Reading

Biofeedback Training Is a Good Alternative to Preventive Medication for Migraine and Tension-Type Headache
Migraine ICYMI
Switch from anti-CGRP receptor to anti-CGRP ligand mAb offers promise in treatment-refractory chronic migraine
Migraine ICYMI
Commentary: Vasodilation, antihypertensive drugs, and caffeine in migraine, August 2023
Migraine ICYMI
Benefits of atogepant extended to chronic migraine
Migraine ICYMI
CGRP mAb can be used for migraine prevention in veterans at risk for COVID-19
Migraine ICYMI
Study supports long-term benefits of galcanezumab in episodic migraine
Migraine ICYMI
Anti-CGRP mAb equally effective when restarted in patients with migraine
Migraine ICYMI
Triptans and ergotamine lower ischemic cardio-cerebrovascular diseases risk in migraine
Migraine ICYMI
Add-on MIND outperforms treatment as usual in chronic migraine and medication-overuse headache
Migraine ICYMI
Ubrogepant effective for acute treatment of migraine when taken with onabotulinumtoxinA
Migraine ICYMI